Hydromorphone and Drug dependence: is the FAERS signal real?
Hydromorphone ↔ Drug dependence
Hydromorphone is a potent mu-opioid agonist; tolerance, physical dependence, and addiction are intrinsic to chronic opioid exposure, and drug dependence carries 35,112 co-reports here (PRR 63.1). The risk is amplified with high doses, long duration, and pre-existing substance-use disorder, which is why opioid-prescribing guidelines emphasise cautious initiation and tapering.
Regulatory basis: hydromorphone prescribing information — dependence/abuse; opioid class boxed warning.
| Bradford Hill viewpoint | Status | Note |
|---|---|---|
| Temporality (necessary) | met | Dependence develops with chronic use |
| Strength | met | PRR 63.1, very large |
| Consistency | met | Universally reproduced |
| Specificity | met | Shared across all mu-opioids |
| Biological gradient | met | Rises with dose and duration |
| Plausibility | met | Mu-opioid-receptor adaptation |
| Coherence | met | Fits the mechanism exactly |
| Experiment | met | Long-term studies support it |
| Analogy | met | Direct class analogy to other opioids |
This table is this page's own qualitative read of the literature cited above, not an automated or citation-gated assessment — see the note at the bottom of this page.
✓ Trial evidence found — Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration (NCT01709747)
| Adverse event | Hydromorphone Hydrochloride (n=364) |
|---|---|
| Drug Withdrawal Syndrome | 1/364 |
Post-marketing signal terms appear in this trial's posted adverse-event tables; per-arm counts shown as affected/at-risk. View on ClinicalTrials.gov →